Axogen Inc has a consensus price target of $15.6, established from looking at the 13 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, Canaccord Genuity, and Leerink Partners on January 19, 2024, December 7, 2023, and October 16, 2023. With an average price target of $10.67 between Cantor Fitzgerald, Canaccord Genuity, and Leerink Partners, there's an implied 63.60% upside for Axogen Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
01/19/2024 | AXGN | Buy Now | Axogen | $6.52 | 84.05% | Cantor Fitzgerald | Ross Osborn | → $12 | Reiterates | Overweight → Overweight | Get Alert |
12/07/2023 | AXGN | Buy Now | Axogen | $6.52 | 68.71% | Canaccord Genuity | Caitlin Cronin | → $11 | Reiterates | Buy → Buy | Get Alert |
10/16/2023 | AXGN | Buy Now | Axogen | $6.52 | 38.04% | Leerink Partners | Mike Kratky | → $9 | Initiates | → Outperform | Get Alert |
09/26/2023 | AXGN | Buy Now | Axogen | $6.52 | 145.4% | Cantor Fitzgerald | Ross Osborn | → $16 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | AXGN | Buy Now | Axogen | $6.52 | 145.4% | Cantor Fitzgerald | Travis Steed | → $16 | Reiterates | Overweight → Overweight | Get Alert |
05/10/2023 | AXGN | Buy Now | Axogen | $6.52 | 206.75% | JMP Securities | David Turkaly | → $20 | Reiterates | → Market Outperform | Get Alert |
03/28/2023 | AXGN | Buy Now | Axogen | $6.52 | 130.06% | Canaccord Genuity | Kyle Rose | → $15 | Reiterates | → Buy | Get Alert |
03/15/2023 | AXGN | Buy Now | Axogen | $6.52 | 206.75% | JMP Securities | David Turkaly | → $20 | Reiterates | → Market Outperform | Get Alert |
11/11/2022 | AXGN | Buy Now | Axogen | $6.52 | 130.06% | Jefferies | Michael Sarcone | → $15 | Assumes | → Buy | Get Alert |
05/09/2022 | AXGN | Buy Now | Axogen | $6.52 | 130.06% | Canaccord Genuity | Kyle Rose | $10 → $15 | Upgrade | Hold → Buy | Get Alert |
05/05/2022 | AXGN | Buy Now | Axogen | $6.52 | 114.72% | SVB Leerink | Danielle Antalffy | $12 → $14 | Maintains | Outperform | Get Alert |
11/04/2021 | AXGN | Buy Now | Axogen | $6.52 | 206.75% | JMP Securities | — | — | Maintains | Market Outperform | Get Alert |
05/06/2021 | AXGN | Buy Now | Axogen | $6.52 | 268.1% | Canaccord Genuity | — | — | Maintains | Hold | Get Alert |
The latest price target for Axogen (NASDAQ: AXGN) was reported by Cantor Fitzgerald on January 19, 2024. The analyst firm set a price target for $12.00 expecting AXGN to rise to within 12 months (a possible 84.05% upside). 6 analyst firms have reported ratings in the last year.
The latest analyst rating for Axogen (NASDAQ: AXGN) was provided by Cantor Fitzgerald, and Axogen reiterated their overweight rating.
The last upgrade for Axogen Inc happened on May 9, 2022 when Canaccord Genuity raised their price target to $15. Canaccord Genuity previously had a hold for Axogen Inc.
There is no last downgrade for Axogen.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axogen, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axogen was filed on January 19, 2024 so you should expect the next rating to be made available sometime around January 19, 2025.
While ratings are subjective and will change, the latest Axogen (AXGN) rating was a reiterated with a price target of $0.00 to $12.00. The current price Axogen (AXGN) is trading at is $6.52, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.